1. The AIDS epidemic: the spread of a deadly disease in the biotech era.
- Author
-
Noë A, Verhofstede C, and Plum J
- Subjects
- Acquired Immunodeficiency Syndrome drug therapy, Adult, Africa epidemiology, Antiretroviral Therapy, Highly Active, Asia epidemiology, Australia epidemiology, Child, Europe epidemiology, Female, HIV-1 drug effects, HIV-2 drug effects, Humans, Latin America epidemiology, Male, Middle Aged, North America epidemiology, Prevalence, South America epidemiology, Zidovudine therapeutic use, Acquired Immunodeficiency Syndrome epidemiology, Disease Outbreaks statistics & numerical data
- Abstract
In the last two decades we have witnessed the progression of a newly introduced infection in humans. It is sobering that despite a world-wide effort and the tremendous progression of technical capabilities and scientific knowledge we are still not able to control the global epidemic of HIV. In 2004 more than 40 million people were infected. Educational approaches to modify risk-taking behavior is still the most critical component of prevention and the most important measure to limit the spread of the infection. Vaccine development, which is still far from promising, is probably the only way to control the disease in the future.
- Published
- 2004